Niflumic Acid in the Treatment of Rheumatoid Arthritis: A Short Term Controlled Study

Abstract
A double blind cross-over trial was carried out to compare niflumic acid 750 mg daily with indo-methacin 75 mg daily, each over a 5-day period, in female in-patients with definite rheumatoid arthritis. There was no overall statistical difference between the two drugs with regard to efficacy.